These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 29958681)

  • 21. Isolation and characterization of thermal degradation impurity in brimonidine tartrate by HPLC, LC-MS/MS, and 2DNMR.
    Baksam V; Nimmakayala S; Devineni SR; Muchumarri RMR; Shandilya S; Kumar P
    J Pharm Biomed Anal; 2021 Oct; 205():114297. PubMed ID: 34391137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using the fundamentals of adsorption to understand peak distortion due to strong solvent effect in hydrophilic interaction chromatography.
    Gritti F; Sehajpal J; Fairchild J
    J Chromatogr A; 2017 Mar; 1489():95-106. PubMed ID: 28193468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impurity profile tracking for active pharmaceutical ingredients: case reports.
    Zhou L; Mao B; Reamer R; Novak T; Ge Z
    J Pharm Biomed Anal; 2007 Jun; 44(2):421-9. PubMed ID: 17142001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and identification of a major impurity in a new bulk drug candidate by preparative LC, ESI-MS(n), LC-MS-MS, and NMR.
    Li N; Yang J; Qin F; Li F; Gong P
    J Chromatogr Sci; 2007 Jan; 45(1):45-9. PubMed ID: 17254383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development, validation and transfer into a factory environment of a liquid chromatography tandem mass spectrometry assay for the highly neurotoxic impurity FMTP (4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine) in paroxetine active pharmaceutical ingredient (API).
    Borman PJ; Chatfield MJ; Crowley EL; Eckers C; Elder DP; Francey SW; Laures AM; Wolff JC
    J Pharm Biomed Anal; 2008 Dec; 48(4):1082-9. PubMed ID: 18835674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of LC-MS(n) in conjunction with mechanism-based stress studies in the elucidation of drug impurity structure: rapid identification of a process impurity in betamethasone 17-valerate drug substance.
    Li M; Lin M; Rustum A
    J Pharm Biomed Anal; 2008 Dec; 48(5):1451-6. PubMed ID: 18977106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Applications of high-resolution recycling liquid chromatography: From small to large molecules.
    Gritti F; Besner S; Cormier S; Gilar M
    J Chromatogr A; 2017 Nov; 1524():108-120. PubMed ID: 28989029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of an artificial solution degradant of linagliptin: An undesired linagliptin urea derivative generates in sample preparation of linagliptin tablet treated by sonication in acetonitrile containing diluent.
    Lin J; Chen F; Bao C; Ma J; Li D; Zheng L; Zhu W; Chen W; Liu X
    J Pharm Biomed Anal; 2022 Feb; 210():114540. PubMed ID: 34954487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orthogonal analytical screening for liquid chromatography-mass spectrometry method development and preparative scale-up.
    Font LM; Fontana A; Galceran MT; Iturrino L; Perez V
    J Chromatogr A; 2011 Jan; 1218(1):74-82. PubMed ID: 21122868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of pharmaceutical impurities in formulated dosage forms.
    Pan C; Liu F; Motto M
    J Pharm Sci; 2011 Apr; 100(4):1228-59. PubMed ID: 24081463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and Structural Elucidation of New Process Impurity in Testosterone.
    Gupte V; Luthra U; Desai N
    J Chromatogr Sci; 2018 May; 56(5):403-408. PubMed ID: 29554236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impurity profiling of ibandronate sodium by HPLC-CAD.
    Wahl O; Holzgrabe U
    J Pharm Biomed Anal; 2015 Oct; 114():254-64. PubMed ID: 26092222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification, isolation and characterization of process related impurities in ezetimibe.
    Guntupalli S; Ray UK; Murali N; Gupta PB; Kumar VJ; Satheesh D; Islam A
    J Pharm Biomed Anal; 2014 Jan; 88():385-90. PubMed ID: 24176742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LC-MS characterization of trace impurities contained in calcium folinate.
    Francese G; Corana F; Meneghetti O; Marazza F
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):757-63. PubMed ID: 15927438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The application of LC-NMR and LC-MS for the separation and rapid structure elucidation of an unknown impurity in 5-aminosalicylic acid.
    Novak P; Tepes P; Fistrić I; Bratos I; Gabelica V
    J Pharm Biomed Anal; 2006 Mar; 40(5):1268-72. PubMed ID: 16253464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A quality evaluation strategy for multi-sourced active pharmaceutical ingredient (API) starting materials.
    Gavin PF; Olsen BA; Wirth DD; Lorenz KT
    J Pharm Biomed Anal; 2006 Jun; 41(4):1251-9. PubMed ID: 16621411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enrichment and purification of peptide impurities using twin-column continuous chromatography.
    Weldon R; Müller-Späth T
    J Chromatogr A; 2022 Mar; 1667():462894. PubMed ID: 35219108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural elucidation of a process-related impurity in ezetimibe by LC/MS/MS and NMR.
    Raman B; Sharma BA; Butala R; Ghugare PD; Kumar A
    J Pharm Biomed Anal; 2010 May; 52(1):73-8. PubMed ID: 20079995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification, isolation and characterization of potential process-related impurity and its degradation product in vildagliptin.
    Kumar N; Devineni SR; Singh G; Kadirappa A; Dubey SK; Kumar P
    J Pharm Biomed Anal; 2016 Feb; 119():114-21. PubMed ID: 26678178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.